MANIFESTATION OF COVID-19 IN THE FORM OF ACUTE MYOCARDIAL INFARCTION (case report)
PDF

Keywords

COVID-19, acute myocardial infarction, thrombosis, «cytokine storm».

Abstract

Acute myocardial infarction is necrosis of any myocardial mass due to ischemia. COVID-19 can be complicated by thrombosis and myocardial damage, which can lead to the deployment of a clinical picture similar to acute myocardial infarction. The material of this article is presented on the example of a clinical case. A woman aged 37 was diagnosed with an acute myocardial infarction, which later turned out to be a manifestation of a complicated course of coronavirus COVID-19 infection. This case drew attention to the absence of a clinical picture specific to this infection in the form of a damage to the respiratory system or intoxication. The case is also distinguished by the presence of a single uncharacteristic clinical manifestation of COVID-19 in the form of a cardiovascular event with elevations of the ST segment on the cardiogram and other objective data and additional research methods characteristic of acute myocardial infarction. The work also analyzed the pathogenetic mechanisms of acute myocardial infarction and cardiovascular complications of COVID-19, examined the general links of pathogenesis of these two pathological units and analyzed the causes of difficulties in their differential diagnosis. In this regard, there are unquestionably complications of differential diagnosis and the prescription of timely correct therapy. A deeper understanding of these data may improve the algorithms for diagnosing acute myocardial infarction and cardiovascular complications of COVID-19.

https://doi.org/10.35339/ic.7.4.180-183
PDF

References

Spuntarelli, V, Lucian. i, M., Bentivegna, E., Marini, V, Falangon. e, F, Confort. I., G., ... Martelletti, P. (2020). COVID-19: is it just a lung disease? A case-based review. SN Compr Clin Med, 2020 Jul 28, 1–6.

Moore, J. B., June, C. H. (2020). Cytokine release syndrome in severe COVID-19. Science, 368(6490), 473–474.

Li, L., Zhou, Q., Xu, J. (2020). Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019. Biomed Res Int, 2020:7413673.

Unificovaniy klininchniy protocol ekstreno`i, pervino`I (spetsializovano`i) I tretyno`I(vysokospetsializovano`i) medychno`i dopomogy ta medychno`i reabilitatsi`i "Gostriy koronarniy syndrome z elevatsieyu segmenta ST". Nakaz MOZ Ukra`iny No. 455 [Unified clinical protocol of emergency, primary, secondary (specialized) and tertiary (highly specialized) care and medical rehabilitation "Acute coronary syndrome with ST segment elevations."Order of the Ministry of Health of Ukraine No. 455]. (02.07.2014)

Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., … Uriel, N. (2020). COVID-19 and cardiovascular disease. Circulation, 141, 1648–1655.

Imazio, M., Klingel, K., Kindermann, I., Brucato, A., De Rosa, F. G., Adler, Y., De Ferrarri, G. M. (2020). COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis. BMJ, 106(15), 1127-1131. doi: 10.1136/heartjnl-2020-317186.

Yueying Wang, Zhaojia Wang, Gary Tse, Lin Zhang, Elaine Y Wan, Yutao Guo,… , Tong Liu (2020). Cardiac arrhythmias in patients with COVID-19. J Arrhythm., 36(5), 827–836.

Yuki Nakamura, Masaru Shimizu, Taeka Yamaki, Kohsuke Kushimoto, Ayahiro Yamashita, KazumaHayase,…, Bon Ohta (2020). Myocardial injury in a patient with severe coronavirus disease: A case report. J Infect Chemother, S1341-321X(20)30343-3.

Jose, R.J., Manuel A. COVID-19 cytokine storm: the interplay between inflammation and coagulation., Lancet Respir Med, 8, e46-e47. doi: 10.1016/S2213-2600(20)30216-2.

Chen, C., Chen, C., Yan, J., Zhou, N., Zhao, J. P, Wan. g, D. W. (2020). Analysis of myocardial injury in patients with COVID?19 and association between concomitant cardiovascular diseases and severity of COVID-19. Zhong Hua Xin Xue Guan Bing Za Zhi, 48, E008. doi: 10.3760/cma.j.cn112148-20200225-00123.

Matthew, Z. T., Poh, C. M., Renia, L., MacAry, P. A., Lisa F.P.Ng (2020). The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews Immunology, 1-2.

Ali, A., Boutjdir, M., Aromolaran, A.S. (2018). Cardiolipotoxicity, inflammation, and arrhythmias: role for interleukin-6 molecular mechanisms. Front Physiol, 9, 1866.

Kozlov V. K. (2010). Tsitokinoterapiya: patogeneticheskaya napravlennost` pri infektsionnyh, zabolevaniyah I klinincheskaya effectivnost`: rukovodstvo dlya vrachey. [Cytokine Therapy: Pathogenetic Focus in Infectious Diseases and Clinical Effectiveness: A Guide for Physicians.] St. Petersburg: Alter Ego; 2010. p.148.

Dontsov, A. V. (2013). Effektivnost` dalargina v korrektsii tsitokinovogo profilya u bol`nyh IBS i metabolicheskim sindromom [Effectiveness of dalargin in cytokine profile correction in patients with CAD and metabolic syndrome.] Kursk scientific and practical bulletin "Human and his health", (1), p. 48–51.

Kishimoto, T., Akira, S., Taga T. (1992). IL-6 receptor and mechanism of signal transduction. International J Immunopharmacology, 14(3), 431–438. doi: 10.1016/0192-0561(92)90173-I.

Nishiga, M., Wang, D. W, Ha. n, Y, Lewi. s, D.B., Wu, J.C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol, 17(9), 543–558. s41569-020-0413-9.

Madjid, M., Safavi-Naeini, P., Solomon, S. D. & Vardeny, O. (2020). Potential effects of coronaviruseson the cardiovascular system: a review. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1286

Pavan, K., Bhatraju, Bijan J. Ghassemieh, Michelle Nichols, Richard Kim, Keith R. Jerome Arun, K. Nalla, … T. Eoin West (2020). COVID-19 in critically ill patients in the Seattle region – case series. N. Engl. J. Med, 382, 2012–2022.

Steven Siu-lung Li 1, Cheung-wah Cheng, Chiu-lai Fu, Yiu-han Chan, Man-po Lee, Johnny Waiman Chan, Siu-fung Yiu (2003). Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study. Circulation, 108, 1798–1803.

Rojulpote C, Gonuguntla K, Patil S, Bhattaru A, Bravo PE. (2020). COVID-19 and the Heart.Colomb Med (Cali), 30, 51(2), e4320.

Guido Tavazzi, Carlo Pellegrini, Marco Maurelli, Mirko Belliato, Fabio Sciutti , Andrea Bottazzi,…Eloisa Arbustin (2020). Myocardial localization of coronavirus in COVID-19 cardiogenic shock. Eur J Heart Fail, 2020:1828.

ESC Guidelines for the management of acute myocardial infarction in patients presenting withST-segment elevation (2017). Eur Heart J, 39(21), 119–177. doi: 10.1093/eurheartj/ehx393.

Sripal Bangalore, Atul Sharma, Alexander Slotwiner (2020). ST-Segment Elevation in Patientswith Covid-19 - A Case Series. N Engl J Med, 382, 2478–2480.

Yenercag, M., et al. (2020). Evaluation of electrocardiographic ventricular repolarization variables in patients with newly diagnosed COVID-19. J Electrocardiol, 62, 5-9. PMID: 32731139.

Tan, Z. C., Fu, L. H., Wang, D. D., Hong K. (2020). Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations. Zhonghua Xinxueguanbing Zazhi, 48, E005. doi: 10.3760/cma.j.issn.cn112148-20200213-00077.

Clerkin, K. J., Fried, J. A., Raikhelkar, J., Sayer, G., Griffin, J. M., Masoumi, A., Jain, S. S., ... Uriel, N. (2020). Coronavirus disease 2019 (COVID-19) and cardiovascular disease. Circulation, 141(20), 1648-1655. doi: 10.1161/CIRCULATIONAHA.120.046941. PMID: 32200663.

Masataka Nishiga, Dao Wen Wang, Yaling Han, David B. Lewis, Joseph C. (2020). COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology, 17(9), 543-558. doi: 10.1038/s41569-020-0413-9. PMID: 32690910; PMCID: PMC7370876.

Stefanini, G. G., Montorfano, M., Trabattoni, D., Andreini, D., Ferrante, G., Ancona, M., … Chieff, A. (2020). ST-Elevation Myocardial Infarction in Patients With COVID-19. Circulation, 141, 2113–2116.

Copyright for articles published in the journal is regulated by the License Agreement for the use of a scientific article in the journal, which is concluded between the author of the article (Licensor) and Kharkov National Medical University (Licensee, publisher of the journal "Inter Collegas"). The licensor grants to the Licensee a non-exclusive non-exclusive license for the use of the article (a license that does not exclude the use of the article by the Licensor and the issuance of licenses to others for use of this article) on the terms and for the period specified in the contract. The licensor (the author of the article) grants the Licensee the right to reproduce the article (publication in the journal "Inter Collegas", publication, duplication, duplication or other reproduction of the article without limiting the circulation of copies, each copy of the article must contain the name of the Licensor; Of general information, including the publication of the article in full or in part on the Internet on the journal page, the right to use the metadata of the article (titles, full names of authors, annotations, bibliography eskih materials) through the dissemination and communication to the public, processing and systematization, as well as inclusion in various databases and in-formational system).

The licensor grants the licensee the right to transfer, store and process his personal data (full name, scientific degree, academic title, place of work and position, contact information of the authors) with the purpose of including them in the database in accordance with the Law of Ukraine No. 2297 - VI "on protection of personal data" from 01.06.2010.

Personal data and metadata of the article are provided for their storage and processing in various databases and information systems, including them in analytical and statistical reporting, creating sound relationships between the objects of works of science, literature and art with personal data, etc. on unlimited territory. The licensee has the right to transfer the specified data for processing and storage to third parties provided that such a fact is notified with the provision of information about the third party (name and address) to the Licensor.